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Generation of reactive oxygen species (ROS) is a ubiquitous phenomenon in eukaryotic cells’ life. Up to the 1990s of the past
century, ROS have been solely considered as toxic species resulting in oxidative stress, pathogenesis and aging. However, there is
now clear evidence that ROS are not merely toxic species but also—within certain concentrations—useful signaling molecules
regulating physiological processes. During intense skeletal muscle contractile activity myotubes’ mitochondria generate high ROS
ﬂows: this renders skeletal muscle a tissue where ROS hold a particular relevance. According to their hormetic nature, in muscles
ROS may trigger diﬀerent signaling pathways leading to diverging responses, from adaptation to cell death. Whether a “positive”
or “negative” response will prevail depends on many variables such as, among others, the site of ROS production, the persistence
of ROS ﬂow or target cells’ antioxidant status. In this light, a speciﬁc threshold of physiological ROS concentrations above which
ROS exert negative, toxic eﬀects is hard to determine, and the concept of “physiologically compatible” levels of ROS would better
ﬁt with such a dynamic scenario. In this review these concepts will be discussed along with the most relevant signaling pathways
triggered and/or aﬀected by ROS in skeletal muscle.
1.Introduction
Oxidative stressors, such as reactive oxygen species (ROS),
have been initially and long considered as merely delete-
rious species to skeletal muscle tissue. Indeed, since the
1980s abundant evidence clearly indicated that ROS play
a pathogenic role in inherited muscular dystrophies [1]
and have then been identiﬁed as concausal factors in
various muscular diseases [2–5]. However, and thereafter,
accumulating evidence indicated that ROS, at least within
concentrations emerging from physiological conditions,
could also play a positive role in physiologically relevant
processes in muscle cells. As an example, inﬂammation-
derived ROS play a contradictory role in muscle repair [2]:
i nc o m b i n a t i o nw i t ho t h e ra c t o r ss u c ha sg r o w t hf a c t o r s
and chemokines, ROS participate in a cascade of events
leading to muscle regeneration and repair; on the contrary,
the local persistence of ROS sustained by inﬁltrated neu-
trophils may cause further injury by oxidatively damaging
diﬀerentiating myoblasts and myotubes thus delaying the
restitutio ad integrum. Similarly, ROS generated during
exercise promote mitochondriogenesis (a key factor in mus-
cle diﬀerentiation) via peroxisome proliferator-activated-
receptor-gamma-coactivator-1α-(PGC-1α) activated signal
transduction pathway [3] but, at higher and persistent levels,
they might target mitochondria and mitochondrial DNA
(mtDNA) turning into blockers of myogenic diﬀerentiation
[4, 5]. Other examples of such diverging capacities—which
strengthen the generally accepted notion that ROS act
in a hormetic fashion—will be discussed thereafter. The
prevalence of each of the two actions, that is, beneﬁcial or
detrimental, depends on the coincidence of various intrinsic
and extrinsic factors among which the most prominent
is the level and the duration of ROS targeting muscle
cells; other variables are the source or the site of ROS
generation, the antioxidant status of target cells, and their
DNA repair capacity. The diﬀerentiation stage of muscle cells
(satellite cell, diﬀerentiating myoblast or mature myotube)
is also capable of redirecting the cell through diﬀerent
signaling pathways and of further modulating the ensuing
cell response. Today ROS are known to trigger and/or aﬀect
many signaling pathways relevant to skeletal muscle cells’2 Journal of Signal Transduction
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Figure 1: Major signaling pathways triggered and/or aﬀected by ROS in skeletal muscle. Low levels of ROS activate speciﬁc key signaling
molecules such as PGC-1α, AMPK, and MAPK, which control cellular mechanisms for muscle adaptation (oxidative metabolism,
mitochondrial biogenesis, and mitochondrial functionality) as well as antioxidant enzymes that function as backregulators of intracellular
ROS levels. Slight ROS accumulation also inhibits PPases and promotes the phosphorylation state of many proteins involved in the muscle
signaling responses. Moreover, low levels of ROS play an important role in inducing upregulation of growth factors such as IGF-1, which
has beneﬁcial eﬀects in muscle protein balance, supports oxidative metabolism, and contributes to the development of an oxidant-resistant
phenotype,thereforepreventingoxidativedamageandchronicdiseases.Thus,lowlevelsofROSelicitpositiveeﬀectsonphysiologicalmuscle
responses. By contrast high levels of ROS cause functional oxidative damages of proteins, lipids, nucleic acids and cell components, induce a
signiﬁcantriseofintracellular[Ca2+],andpromotesignalingcascadesforapoptosisorautophagyviaNF-κBorFoxOpaths.Forthesereasons
high ROS levels are reputed to act as etiological, or at least exacerbating factors in muscle atrophy, sarcopenia, wasting, and chronic-/aging-
related muscle diseases and myopathies. Depending on their level/persistence, ROS may also turn the same process from “physiologic” into
“pathologic”, as in the case of inﬂammation.
homeostasis and adaptation: here we will illustrate some of
the signaling pathways triggered/aﬀected by ROS in muscle
tissueandtheirphysiopathologicalimplications(seeFigure 1
for a visual summary).
2. Generation of ROS in Skeletal Muscle Cells
Mitochondria are commonly considered as the predominant
source of ROS in skeletal muscle cells [6, 7]. Increased
mitochondrial ROS generation occurs during various and
diﬀerent situations, such as in the course of intense con-
tractile activity [8] or in response to cytokines such as
tumor necrosis factor-α (TNF-α)[ 9]. Early reports assumed
that 2–5% of the total oxygen consumed by mitochondria
may undergo one electron reduction with the generation
of superoxide [10, 11]. More recent studies indicated that
complexes I and III of the electron transport chain are
the main sites of mitochondrial superoxide production [12,
13]. During exercise, it is assumed that the increased ROS
generation in the course of contractile activity is due to the
high oxygen consumption that takes place during increased
mitochondrial activity. Indeed superoxide generation in
skeletal muscle increases to about a 50- or 100-fold during
aerobic contractions [14, 15].
However, recent evidence demonstrates that mitochon-
dria may not be the prevalent source of ROS during exercise
[8], and future studies are required to better elucidate the
mitochondrial role in contraction-induced production of
ROS in skeletal muscle. In 2002 St. Pierre and colleagues
[16] reexamined the rate of mitochondrial ROS production
and concluded that the total fraction of oxygen converted
into superoxide was equal to 0.15%; this value is signiﬁcantly
lower than that (2–5%) estimated by other authors (see for
example [17]). This lower rate of superoxide production
takes account of the uncoupling proteins role (speciﬁcally
UCP3 in skeletal muscle) as regulators of mitochondrial
ROS production [18, 19] acting to prevent oxidative damage
to mitochondria. In addition, growing evidence highlights
that mitochondria produce more ROS during the basal
state 4 of respiration as compared to state 3 (maximal
ADP-stimulated respiration) [20–23]. Thus, since skeletal
muscle mitochondria, during aerobic contractile activity,
are predominantly in state 3, this limits their capacity of
generating ROS during contractions [21–23].Journal of Signal Transduction 3
Mitochondria are not the main and only source of ROS
production in skeletal muscle during exercise. Indeed, other
relevant sources of ROS production within muscle cells
are nicotinamide adenine dinucleotide phosphate (NADPH)
oxidases (NOXs) located within the sarcoplasmic reticulum,
transverse tubules, and the sarcolemma [24, 25].
Phospholipase A2 (PLA2) is another known source of
intracellularROSproduction[17].Arachidonic acidreleased
from cell membranes by PLA2 is a substrate for ROS-
generating enzyme systems such as the lipoxygenases [26].
Activation of PLA2 can stimulate NOXs [27] and increased
PLA2 activity can promote ROS production in muscle
mitochondria [28]a n dc y t o s o l[ 29] and release ROS into
the extracellular space [26]. Both calcium-dependent and
-independentformsofPLA2existinskeletalmuscleandboth
contribute to muscle ROS generation [17]. In particular,
the calcium-independent isoforms are likely to be involved
in cytosolic oxidant activity in skeletal muscle cells [29],
whereasa14-kDacalcium-dependentisoformlocatedwithin
mitochondria is reputed to stimulate mitochondrial ROS
generation during contractile activity [30]. In this light it has
been proposed [29] that the calcium-independent PLA2 is a
major determinant of ROS activity under resting conditions,
whereas during processes or stress elevating intracellular cal-
cium concentration (contraction, inﬂammation, heat stress,
etc.) the calcium-dependent PLA2 is activated to promote
ROS production.
Finally, superoxide anion is known to be generated by
xanthine oxidase (XO) in the cytosol of contracting rat
skeletal muscles cells [31]. However, human skeletal muscles
contain lower levels of XO than rat muscle cells, and the
question whether XO plays an important role in superoxide
production in human skeletal muscle is still open [31, 32].
More ROS-generating mechanisms may be operative at the
sametime,asinthecaseofprolongedmuscleischemiawhere
mitochondrial and cytoplasmic (via XO) ROS production
has been simultaneously scored [33].
ROS can be generated through the above mechanisms
not only within muscle cells but also in their proximity. For
instance, during inﬂammation (a pathophysiological state
that substantially alters cellular oxidative/antioxidant home-
ostasis) inﬁltrated polymorphoneutrophils activate NOX
producingROSviatherespiratoryburstandmanycytokines,
which amplify in a feedforward cycle ROS production,
are secreted within muscles [34]. For instance, during
the early phase of muscle injury, inﬂammatory cytokines
can bind to membrane receptors and activate speciﬁc
ROS-generating enzymes, such as cyclooxygenase-2, NOX,
and XO [35]. Endothelial cells from injured muscle are
known to secrete TNF-α, interleukine (IL)-1, IL-6, and IL-
8, providing a positive feedforward cycle [36]. Whereas a
transient oxidative stress is necessary in inﬂamed muscle
cells to exert an antiseptic function and to activate various
signal transduction pathways relevant to the restitutio ad
integrum, prolonged severe oxidative stress may imbalance
intracellular antioxidant homeostasis and hence long-term
muscle welfare.
The oxygen-centered species that mostly arises from
the processes described so far is superoxide anion, but its
signiﬁcance in ROS signaling pathways seems to be limited
toaroleasaprecursorsignalingmolecule.Indeedsuperoxide
undergoes enzymatic or spontaneous dismutation, a process
generating H2O2.H 2O2 is a nonradical, is a weak oxidant
with a relatively long half-life allowing its diﬀusion within
cells and across cell membranes [37], reacts with many
diﬀerent cellular molecules, and activates a wide number of
signaling pathways. These properties render H2O2 the most
relevant ROS signaling molecule in cells [38]. In contrast,
H2O2 undergoing Fenton chemistry in the presence of redox
active free iron ions or other transition metals can give
rise to hydroxyl radicals, which react immediately with any
surrounding biomolecules exerting most of the deleterious
eﬀects associated with oxidative stress. In this light, iron
homeostasis can be considered as a comodulator of ROS
signaling and eﬀects. In particular, since skeletal muscle
contains 10 to 15% of body iron—mainly in myoglobin
andmitochondria—it couldbeparticularlysensitivetoalter-
ations of iron homeostasis: accordingly it has been recently
reported that levels of muscle nonheme iron and the iron
transport protein, transferrin were elevated in senescence,
suggesting that iron load is a signiﬁcant component of
sarcopenia [39].
3. AntioxidantsandModulation of
MuscleCells’SensitivitytoROS
As it will be discussed throughout this review, the net eﬀect
of ROS on cells’ signaling pathways and fate depends also
onthecellularantioxidantcapacity.Theantioxidantnetwork
consists of enzymes, such as catalase, glutathione peroxidase
(GPx), thioredoxin reductases (TRxs), superoxide dismu-
tases (SODs), and soluble antioxidants such as glutathione
(GSH) and vitamin E. Depending on its eﬃcacy, the antiox-
idant cellular network plays a primary role in maintaining
ROS below a physiologically compatible threshold level, thus
allowing ROS to serve, theoretically, as signaling molecules
and avoiding them to exert direct toxic eﬀects. Many
antioxidant enzymes are known to be induced in response to
increased ROS generation. The increased ROS ﬂux occurring
in the course of strenuous exercise, through redox-sensitive
mechanisms, induces the expression of γ-glutamylcysteinyl
synthetase, the rate-limiting enzyme of GSH synthesis, of
GPx, and of MnSOD [40] .N u c l e a rF a c t o rK a p p a B( N F - κB),
activator protein 1 (AP-1), and mitogen-activated protein
kinases (MAPKs) have been identiﬁed as the major signaling
pathways that can be activated by exercise-derived ROS and
directly involved in the induction of the above antioxidant
enzymes [40]. For instance, in the signaling path of MnSOD
gene expression, NF-κB and AP-1 play an important role
[41]: both NF-κB and AP-1 binding sites are present in the
promoter of the mammalian MnSOD gene, and ROS have
been shown to activate their binding.
The above responses, whose extent might be genetically
predetermined, represent a fundamental adaptive counter-
measuretoconditionspotentiallyresultinginfrankoxidative
stress. A speciﬁc modulator of ROS activity, working in an
“antioxidant-like” fashion in ROS-mediated autophagy and
apoptosis (see also “ROS mediate autophagy and apoptosis”),4 Journal of Signal Transduction
is the p53-inducible glycolysis and apoptosis regulator
(TIGAR), a p53-target gene. Indeed, TIGAR can reduce ROS
levels in response to nutrient starvation or metabolic stress,
thus inhibiting autophagy and apoptosis independently of
mammalian target of rapamycin (mTOR) or p53 modu-
lation [42]. The TIGAR protein functions as a fructose-
2,6-bisphosphatase and contributes to the regulation of
intracellular ROS levels by modulation of the glycolytic
pathway [43]. By decreasing glycolytic rate and redirecting
glycolytic intermediates to the oxidative branch of the
pentose phosphate pathway, TIGAR causes an increase in
NADPHproduction,whichfavoursROSscavengingthrough
GPx/glutathione reductase and GSH cycle. In this manner,
TIGAR lowers the sensitivity of cells to ROS-induced p53-
dependent apoptosis [43].
As to the inﬂuence of physical exercise, it caused an acti-
vation of MAP kinases in gastrocnemius muscle from rats;
this in turn activated the NF-κB pathway and consequently
the expression of SOD and adaptation to exercise through
increasedexpressionofendothelialandinduciblenitricoxide
synthase [40]. All these responses were silenced when ROS
production was prevented by allopurinol [40]. Thus ROS
act as signals in exercise because their scavenging prevents
activation of important signaling pathways promoting useful
adaptations in cells. Because these signals result in an
upregulation of powerful antioxidant enzymes, exercise itself
can be considered an antioxidant.
Besides the established soluble cellular antioxidants,
creatine (Cr) is emerging as a pleiotropic molecule capable
of inﬂuencing muscle cell’s trophism, diﬀerentiation, and
sensitivity to ROS [44, 45]. Cr has a high tropism for
skeletal muscles, where most of body Cr is stored and
has been shown to exert direct and indirect antioxidant
activity in proliferating and diﬀerentiating C2C12 myoblasts
[44] .Ar e c e n ta r t i c l eb yY o u n ge ta l .[ 46] showed that
two TRxs situated in the mitochondria and cytoplasm,
respectively, were increased in Cr-treated C2C12 myoblasts:
peroxiredoxin-4, a type 2 peroxiredoxin, and thioredoxin-
dependent peroxide reductase.
As it will be discussed below, the 5-adenosine mono-
phosphate-activated protein kinase (AMPK) signaling is
critical in regulating mitochondrial content and function in
aP G C - 1 α -dependent pathway in diﬀerent tissues and in
response to various stimuli [47]; furthermore AMPK signal-
ing is important in preventing the mitochondrial dysfunc-
tion/impairment increasing ROS leakage and accompanying
sarcopenia, disuse muscle atrophy, and other degenerative
muscle disorders, in such a way that it can be considered
as an indirect antioxidant cellular setting. Ceddia and
Sweeney [48] ﬁrstly demonstrated that Cr supplementation
may improve cellular bioenergetics by activating AMPK to
improve overall mitochondrial content and/or function. It
is currently unknown whether Cr supplementation exerts
similar AMPK eﬀects in oxidatively injured muscle tissue.
At this regard, we recently observed in either control or
oxidatively challenged diﬀerentiating myoblasts that a 24h
Cr preloading [0.3mM] is an adequate stimulus to activate
the AMPK pathway (unpublished observation).
This observation, along with others showing that Cr
also acts as a direct antioxidant [5, 44, 49, 50]a n dp r o t e c t s
diﬀerentiating myoblasts from H2O2-dependent diﬀerentia-
tive arrest [5], suggests that in oxidative stressing conditions
Cr treatment might confer myoblasts an enhanced adaptive
capacity resulting in increased mitochondrial functionality
and biogenesis and reduction of oxidative damage during
myogenesis.Thus,besidesestablishedantioxidants,Crmight
represent a skeletal-muscle-directed endogenous molecule
capable of exerting multiple, pleiotropic actions which
collectively help counteracting excessive ROS pressure. Con-
sistently, beneﬁcial eﬀects of Cr supplementation have been
reported for a large number of muscular, neurological, and
cardiovascular diseases as well as in sarcopenia and aging
[44, 51–56]. On the contrary, although great attention has
been—and is still—paid to the administration of established
antioxidants including polyphenols and vitamins in order
to reduce the potential risk of the sustained and persistent
action of ROS on skeletal muscle, there is no clear con-
sensus on the beneﬁts of these supplements [40, 57–59].
Thus, exploiting the eﬃcacy of “atypical” and pleiotropic
antioxidants such as Cr deserves consideration.
The integrity of the antioxidant network is particularly
important in aging. Indeed, it is well-established that aging
is associated with increased free radical generation and the
resulting oxidative damage accumulated in organisms are
likely to be involved, at least at a concausal level, in the
progression of numerous diseases [60, 61]. It has long been
suspected that senescent skeletal muscle may progressively
loose its ability to adapt to oxidative stress [62, 63]. However,
at the present, there is no clear consensus about how and
whether senescent skeletal muscle becomes more susceptible
to ROS pressure. For example, although in skeletal muscle
antioxidant enzyme activities are increased with old age
[64, 65], protein and mRNA levels of CuZnSOD, MnSOD,
and GPx were found to be decreased or unaltered in the aged
muscle [66, 67]. More importantly, aged muscle exhibited
reduced antioxidant adaptation compared to training young
muscle [62]. The reduced ability to rapidly activate an
antioxidant adaptation program may render the senescent
muscle more prone to oxidative damage. Notably, it has
been hypothesized that the lack of adaptive capacity in
aging muscle may depend on the impairment of signal
transduction of antioxidant gene expression in response to
oxidative stress [68]. At this regard, as discussed above,
NF-κB and AP-1 are known to play an important role
in MnSOD gene expression [41]. The decreased binding
of these nuclear factors, despite increased ROS generation
found in aged muscles, would suggest that aging slows
down molecular signaling of antioxidant gene expression.
Thus aging seems to decrease the ability of aged muscle to
express at least MnSOD as demonstrated by lower nuclear
proteinbinding,mRNAlevels,andunalteredenzymeprotein
[62]. The observed increase in MnSOD activity in the same
setting might depend on a posttranslational modiﬁcation
(activation) of the enzyme molecules in aged muscle. In
contrast to MnSOD, CuZnSOD showed increased protein
c o n t e n ta n da c t i v i t yw i t ha g ei nt y p eI Im u s c l ei nt h e
absence of mRNA changes [66]. On the whole, these dataJournal of Signal Transduction 5
suggest that the widely reported increase in antioxidant
enzyme activities in aging skeletal muscle do not depend
on enhanced gene transcription, but can rather derive from
translational and/or posttranslational mechanisms. Since
agedskeletalmusclesareaﬀectedbyaugmentedlevelsoflipid
peroxidation, protein oxidation, and DNA damage, these
compensatory increases in antioxidant enzyme activity are
ineﬀective in counteracting increased ROS generation.
4. ROS, MitochondrialBiogenesis andFunction
It is well known that oxidative signals aﬀect mitochondrial
biogenesis, morphology, and function in skeletal muscle cells
[69–71]: again, the eﬀect of ROS seems to be bifaceted
and controversial. Indeed, ROS may be important either
in eliciting pathological eﬀects leading to mitochondrial
dysfunction and cell death ([72, 73], see also below
“Mitochondrial ROS Mediate Autophagy and Apoptosis”),
or play physiological roles promoting positive responses in
mitochondrial biogenesis and function. Mitochondrial bio-
genesis is dependent on the expression of the mitochondrial
genome and the nuclear genes that encode mitochondrial
proteins [74]. An important pathway triggered by ROS
is that leading to the upregulation of the mitochondrial
biogenesismastergenePGC-1α.ThePGC-1αtranscriptional
coactivator is a major regulator of energy metabolism
[75]. It controls many aspects of oxidative metabolism,
including mitochondrial adaptations, insulin-sensitizing via
the upregulation of selected genes involved in fatty acid β-
oxidation, glucose transport, and oxidative phosphorilation
[76–79]. The mitochondrial biogenesis signaling activated
by PGC-1 members family involves the transcription factors
that regulate expression of nuclear genes such as nuclear
respiratory factor (NRF) 1/2 and estrogen-related receptor-
α (ERR-α). These three latter genes control the expression of
nuclear genes encoding mitochondrial proteins and induce
expression of mitochondrial transcription factor A (T-
fam), which regulates mtDNA replication and transcription,
thus activating the coordinated expression of mitochondrial
proteins [80, 81].
Several signaling kinases have been involved in medi-
ating PGC-1α transcriptional activation in response to a
variety of stimuli among which the most important are
calcium/calmodulin-dependent protein kinase (CaMK) type
IV [82], AMPK [83] ,a n dp 3 8m i t o g e n - a c t i v a t e dp r o t e i n
kinase [84]. Their activation induces the PGC-1α promoter
transcriptional regulation [69]. Recently, it has been demon-
strated that mitochondrial biogenesis in skeletal muscle is
controlled, at least in part, by a redox-sensitive mechanism
and that physical exercise, increasing the ROS production
over the physiological level, stimulates the muscle PGC-
1α/NRF-1/T-fam signaling [85]. Irrcher and colleagues have
evaluated the link between ROS levels and PGC-1α gene
expression [69] in C2C12 cells. They found that endoge-
nouslyproducedROS,atleastwithinskeletalmusclecells,are
important for the maintenance of PGC-1α expression levels
within a normal physiological range. Indeed, quenching
basal endogenous ROS with N-acetylcysteine (NAC) results
in reduced PGC-1α mRNA expression, an eﬀect which is
unrelated to any inhibition of PGC-1α promoter activity,
but probably dependent on the enhanced instability of
PGC-1α mRNA occurring in a low ROS environment. On
the contrary, increasing ROS levels with exogenous H2O2
augments PGC-1α transcription indirectly via the AMPK
activation caused by the oxidatively-induced ATP depletion.
This stimulates the binding of USF-1 to an Ebox within
the PGC-1α promoter, increases transcription and results in
the induction of PGC-1α mRNA expression, whose stability
wouldalsoberestoredinamoreROS-richenvironment.The
interplay of PGC-1α and ROS is further strengthened by the
fact that, besides being a key modulator of mitochondrial
biogenesis, it is important in regulating the expression
level of protective enzymes acting against ROS generation
and damage [86]. Indeed, experiments with either genetic
knockouts (KOs) or using RNA interference for PGC1α
show that the ability of ROS to induce a ROS-scavenging
program depends largely on PGC-1α activity [86]. This
response includes genes encoding for antioxidant enzymes
localized either within mitochondria (MnSOD) or cytosol
(catalase and GPxs). Indeed, cells lacking PGC-1α are more
susceptible to the toxicity induced by oxidative stress caused
by H2O2 [86]. These latter eﬀects of PGC-1α are likely to
represent a compensatory response where it plays a central
role in the adaptation of cellular energy metabolism, mito-
chondrial biogenesis and antioxidant capacity in response to
oxidative challenge. At this regard and extending previous
research from our group [5], we have recently addressed
the problem of the role of PGC-1α in C2C12 myoblasts
subjected to oxidative stress during the early stages of
diﬀerentiation. In particular, we examined the eﬀect of
a mildly toxic concentration of exogenously added H2O2
[0.3mM] on the regulation of PGC-1α expression and its
relationship with AMPK activation (unpublished observa-
tions). According to Kang and Irrcher [69, 85], we found
that 1h treatment with H2O2 markedly increased PGC-1α
mRNA expression. It is of worth that, concurrently, we also
found an increased phosphorylation of AMPK as compared
to untreated cells, suggesting that oxidative stress induces
PGC-1α through the AMPK signaling pathway. However,
despite the fact that challenged C2C12 myoblasts rapidly
activate a defense-oriented signaling cascade, they displayed
a 30–40% reduction of their viability as well as a survivors’
reduced diﬀerentiative eﬃciency during the post-challenge
incubation stage (up to 7 days of culture). This observation
would imply that, besides probably being an obligatory
and physiological response to ROS, activation of AMPK
and of PGC-1α may not be suﬃcient to aﬀord a complete
protection to cells against an overwhelming oxidative stress.
Accumulating or excessive oxidative stress is known to be
detrimental for mitochondria: for instance mtDNA repre-
sents a critical target for oxidative damage [49]. Indeed,
mtDNA mutations are known as being an etiological factor
in oxidative stress-related disorders including cardiovascular
diseases and inherited or acquired neurodegenerative dis-
orders, mitochondrial myopathies, and the normal aging
process.6 Journal of Signal Transduction
5. ROS Mediate Autophagy and Apoptosis
ROS may trigger either autophagy or apoptosis: whether
these two pathways will be activated depends on the cell
context and on the availability of speciﬁc modulators of
ROS activity [87]. Autophagy is one of the cellular defense
mechanisms activated in response to an excessive ROS
production. Indeed, ROS act as signaling molecules in the
early events of autophagy induction [87]. Phosphoinositide
3 kinase (PI3K) is known to mediate, at least in part, ROS
eﬀects. If the prosurvival eﬀort fails, ROS induce cell death
which may involve either the autophagic or the apoptotic
pathway, or both [72, 88].
ROS signaling pathways play an important role in the
induction of autophagy under physio- and pathological
conditions. In healthy cells, autophagy is routinely involved
in organelles and proteins turnover as well as in cellular
energetic balance [89]. One of its strongest and better-
characterized stimuli is starvation, where mitochondrial
ROS production is enhanced and autophagy increased [87].
Increased ROS generation in the mitochondria under starva-
tionisknowntodepend,atleastinpart,byclassIIIPI3K:this
eventisessentialfortheinductionofautophagy[90].Indeed,
upon starvation, ROS, and in particular H2O2, oxidize
and inhibit Atg4, a protease responsible for microtubule-
associated protein (MAP) light chain 3 (LC3) delipidation,
that is, a condition resulting in the stabilization of the
lipidated forms of LC3 and promoting the autophagosome
maturation [87]. Notably, the same authors reported that
addition of antioxidants inhibits these eﬀects, preventing
autophagosome biogenesis [91].
Thus, autophagy induced by starvation, where ROS
participate in a feedforward manner, plays a prosurvival role
since it contributes to the mobilization and reutilization of
diverse cellular energy stores [89].
In a diﬀerent direction, it is also known that when
autophagy is prolonged, it could lead to cell death indepen-
dently from apoptosis [92]. Indeed in nonmuscle tissues and
in speciﬁc pathological conditions, ROS-induced autophagy
was often linked to cell demise and death. As to skeletal
muscle, ROS have been implicated in the induction of
autophagy in muscle atrophy, disuse, and aging [72, 93].
Important new evidence on the wasting eﬀect induced
by increased oxidative stress on muscle phenotype was
obtainedbytargetingamutantSODvariantfoundinhuman
amyotrophic lateral sclerosis myopathy [93, 94]. Indeed,
these authors created a mouse model with a G93A mutation
of SOD1 restricted to skeletal muscle [93]: accumulation
of ROS in the muscles of these mice induced progressive
atrophy associated with increased autophagy and forkhead
transcription factors O (FoxO3) expression, a transcription
factor which controls the transcription of autophagy-related
genesandisrequiredfortheinductionofautophagythrough
the lysosomal pathway in skeletal muscle in the absence
of AKT repression [95–97]. In addition, NF-κB signaling
has been proposed as an alternative pathway linked to
ROS-mediated skeletal muscle atrophy [98]: indeed NF-κB
was found to induce muscle atrophy and wasting via the
lysosomal enzyme cathepsin L [93, 99] upregulation. Since
cathepsin L is typically upregulated by FoxO3, it might be
speculatedthatROS-inducedNF-κBconvergesontheFoxO3
autophagic pathway.
Increasing evidence suggests that autophagy of mito-
chondria is a selective and defense-oriented response against
ROS, mitochondrial dysfunction and the accumulation of
somatic mutations of mtDNA with aging [72, 100]. For this
reason it has been recently proposed the term “mitophagy”
to emphasize the nonrandom nature of this process [100].
Damaged mitochondria are removed by mitophagy by
Binp3, a BH3 proapoptotic member of the Bcl-2 family
and ﬁs 1, a pro-ﬁssion mitochondrial protein that induces
mitochondrial fragmentation and enhances the extent of
mitophagy. Notably, inhibition/alteration of mitophagy can
contribute to myoﬁber degeneration and weakness in muscle
disorders characterized by accumulation of abnormal mito-
chondria and inclusions [101, 102].
ROS may have various and important roles in apoptotic
cell death: direct actions such as oxidation of cellular
proteins and lipids, damage of nucleic acids and functional
alteration of organelles; ROS may also modulate cell death
processes aﬀecting various signaling cascades [103]. Indeed,
ROS participate in early and late steps of the regulation of
apoptosis, aﬀecting diﬀerent apoptotic signaling cascades in
both intrinsic or extrinsic pathways.
The extrinsic path, which involves stimulation of recept-
or-mediated apoptotic pathways, can be initiated by ligand-
induced (e.g., TNFα and Fas-L and TNF-related apoptosis-
inducing ligand, TRAIL) binding, which promotes the
activation of caspase-3 and subsequent degradation of
genomicDNA[103].Recentevidencesuggestspossibledirect
roles for ROS in mediating death receptors activation and
subsequent induction of apoptosis [104]. Indeed, apoptotic
signaling is induced by NOX-derived ROS at the plasma
membranelevel,whichleadtolipidraftformationanddeath
receptor clustering activation [104]. The physiological rele-
vance and signiﬁcance of ROS-dependent receptor-mediated
apoptosis as compared to the classical receptor/ligand-
induced apoptotic signaling is, at present, incompletely un-
derstood and warrants further investigation.
ROS may act as intracellular intermediates directly
dysregulating the sarcoplasmic reticulum Ca++ ﬂux and
handling, which results in caspase-7 and calpain activa-
tion. Furthermore, ROS may cause mitochondrial swelling
and fragmentation, and/or alter the conformation of the
mitochondrial permeability transition pores (MPTPs), thus
facilitating their opening and the release of proapoptotic
proteins such as cytochrome c (Cyt C). Independently of
caspase activity, apoptosis may follow the intrinsic path,
where ROS may directly cause the release of mitochondrial
endonuclease G (Endo G), and/or of apoptosis inducing fac-
tor(AIF),whichiscapableofpromotingDNAfragmentation
in skeletal muscle myonuclei [105].
Another protein coupled with ROS-induced apoptosis
is the voltage-dependent anion selective channel protein 1
(VDAC1). This transmembrane protein has been deﬁned a
ROS sensor [106]thattriggersopeningoftheMPTPcomplex
under conditions of oxidative stress. Indeed VDAC1 is the
mainchannelwithinthemitochondrialoutermembraneandJournal of Signal Transduction 7
upon ROS accumulation exhibits an increased conductance
associated with MPTP opening and dissipation of ΔΨ,
thus favouring the eﬄux of apoptotic proteins located
in the intermembrane space and ﬁnally cell death [107].
Notably, the pro- and antiapoptotic Bcl2-family proteins
are released via VDAC1 action and ROS may further aﬀect
these responses as they are known, in nonmuscle cells, to
down-regulate the endogenous levels of the antiapoptotic
protein Bcl-2 [108]. The mechanism through which Bcl-2
levels are aﬀected by ROS has been studied by Azad et al.
in nonmuscle cell types and seems to depend on superoxide
anion-related degradation of Bcl-2 protein through the
ubiquitin-proteasomal pathway [109].
Furthermore, under oxidative stressing conditions, ROS
activate a signaling cascade involving the protein kinase
C (PKC) b-dependent phosphorylation of the Shc adaptor
protein p66shc and its translocation to the mitochondrial
matrix. In particular, the mitochondrially translocated frac-
tionofp66shcbehavesasredoxenzymethatutilizesreducing
equivalents derived from the mitochondrial electron trans-
port chain to produce H2O2 in the intermembrane space, an
event which is known to trigger apoptosis [110, 111].
The accumulation of ROS within the mitochondrial
matrix, as well as their capacity of triggering apopto-
sis, is counteracted/regulated by mitochondrial antioxidant
enzymes, namely, phospholipids hydroperoxide glutathione
peroxidase, GPx, and Mn-SOD [3, 112].
Thus increased mitochondrial production of ROS is
involved at multiple levels in promoting apoptosis in skeletal
muscle cells, an event which participates in the aetiology and
progression of numerous pathologies including sarcopenia
and disuse muscle atrophy as well as in aging [71, 113].
Physical training and exercise are known to increase
mitochondrial biogenesis and density as well as mitochon-
drial ROS production especially during repeated contrac-
tions [85]. Therefore and unless other determinants are
considered, it might appear paradoxical that although a
routine of regular exercise is associated with numerous
health beneﬁts, physical exercise might potentially promote
oxidative stress and ROS-associated apoptosis of skeletal
muscle cells [17]. Indeed, chronic contractile activity (CCA)
and endurance training induce an adaptive response in
skeletal muscle cells leading to increased mitochondrial
biogenesis [114] and—theoretically—an obligatory increase
in a number of proapoptotic mitochondrial proteins and
byproducts such as ROS. However, as a matter of fact
recentevidenceindicatesthatmitochondriaisolatedfromrat
skeletal muscle subjected to CCA seem to acquire an anti-
apoptotic, rather than proapoptotic, behaviour [114]. The
studyalsoaddressedtheproblemoftherelativeantiapoptotic
role acquired by diﬀerent mitochondrial subpopulations
from CCA-trained muscles, namely, the intramyoﬁbrillar
(IMF) and the subsarcolemmal (SS) mitochondria. The
release of both Cyt C and AIF caused by exogenous H2O2
from CCA-isolated IMF and SS mitochondria was decreased;
CCA augmented the expression of antiapoptotic HSP70 and
caspase recruitment domain protein in either SS or IMF and
caused a decreased ROS generation in IMF mitochondria.
On the contrary, states III and IV respiring SS mitochondria
showed a modestly increased rate of ROS generation as well
as an increased resilience of MPTP opening. It was then
hypothesized that these eﬀects might collectively reﬂect the
overall reduced apoptogenic capacity acquired by mitochon-
dria following CCA training of skeletal muscles and that, in
particular, the slight increase of ROS generated by SS would
contribute to the activation of redox-sensitive transcription
factors promoting muscle ﬁber plasticity and adaptation,
rather than to function as proapoptotic triggers. Again, such
a scenario is indicative of the diverging eﬀects that ROS may
assume depending on speciﬁc situations of cells’ life, rather
than on their net concentration and site of generation.
6. ROS SignalingandMyogenic Differentiation
Increasing evidence indicates that ROS are capable of
aﬀecting—mostly reducing—the eﬃciency of myogenic dif-
ferentiation. The integrity/alteration of myogenic diﬀer-
entiation is central to many physiological and pathologi-
cal processes. Successful diﬀerentiation of satellite-derived
myoblasts into functioning and integrated myotubes is a
fundamental prerequisite for muscle regeneration, a repair
process which is of primary importance in maintaining
muscle function [115]. Notably, oxidative stress is known
to play a concausal and detrimental role in a variety of
multifactorial muscular pathologies characterized by prolif-
eration/diﬀerentiation imbalance such as Duchenne dystro-
phy [116], myotonic dystrophy [117], sarcopenia [118], and
cachexia [119].
The role of ROS in this context has been extensively
documented. Ardite et al. [120] showed that ROS induced
a strong depletion of the intracellular GSH pool: notably
depletion of GSH causes further intracellular accumulation
of ROS which favors NF-κB activation, thus contributing to
the lower expression of MyoD and impaired myogenesis (see
below).
According to Ardite et al. [120], data from our group
[5] indicate that a mildly toxic H2O2 treatment during the
earlystagesofC2C12myoblastdiﬀerentiation resultsinGSH
depletion and strongly impairs the diﬀerentiative outcome.
This eﬀect is unlikely to be a mere result of ROS-induced
cell demise: indeed, the cells surviving H2O2, although
exhibiting a partial and late recovery of protein synthesis
and of viability, were unable to continue and execute the
diﬀerentiative task. These cells also displayed a strong and
long-lasting reduction of the mRNA levels of MyoD, which
is involved in early stem cell commitment, and of myogenin
and MRF4, both recruited at later diﬀerentiation times [121,
122]. Whether the transcription of these muscle regulatory
factors (MRFs) is a result of a speciﬁc signaling promoted
b yR O So ro fac e l ls u ﬀering is still to be understood.
Under the same conditions depressing these MRFs, insulin-
like growth factor 1 (IGF-1) which plays a pivotal role
in controlling muscle growth [123], was inhibited to an
even greater extent (see also “ROS and IGF-1 signaling”).
Interestingly, H2O2-injured cells showed signs of extensive
mitochondrial degeneration (swelling and disruption) and
lower mitochondrial density, suggesting that these organelles8 Journal of Signal Transduction
are speciﬁcally targeted by—or particularly sensitive to—
exogenousROS.Lossofmitochondriaisaclearlydetrimental
event in a process typically requiring active mitochondrio-
g e n e s i ss u c ha sm u s c l ed i ﬀerentiation [4, 124].
ROS generated by the inﬂammatory cytokine TNFα
are known to inhibit myogenesis, and this eﬀect is widely
attributed to oxidative activation of NF-κB and subsequent
gene expression [125–127]. However, the eﬀect of TNFα is
likely to be more complex since Langen et al. [9] showed that
TNFα causes loss of myogenic capacity of C2C12 cells via
NF-κB-dependent and-independent and oxidative-sensitive
and-insensitive pathways. In particular they hypothesized
that an oxidative-sensitive, NF-κB-independent mechanism
might involve the blockage of the formation of functional
catenin-adherin complexes proximate to the cell membrane
[128]. Potentially, disruption of these complexes and the
resulting alteration of cell-matrix and cell-cell interactions,
might be responsible for the inhibition of myotube forma-
tion independently of NF-κB.
The redox regulation of the NF-κB family of tran-
scriptional activators plays a central role in diﬀerentia-
tion, adaptation, and death of muscle cells. This role is
extremely complex: indeed the eﬀects promoted by NF-κB
are sometimes contradicting. As an example, although ROS
can directly stimulate NF-κB, oxidized NF-κB has a dimin-
ished DNA-binding activity [17]. NF-κB has been mostly
associated with a negative regulation of skeletal muscle
diﬀerentiation [119, 129, 130]. NF-κB is constitutively active
in proliferating myoblasts and can inhibit myogenesis by
promoting a mitogenic activity viacyclin D1 or by inhibiting
the synthesis of MyoD, a muscle-speciﬁc helix-loop-helix
transcription factor operating in muscle development and
repair [131–133]. More recently, NF-κB was shown to sup-
press myoﬁbrillar gene expression through the regulation of
the myogenic transcriptional repressor Yin Yiang 1 [134].
Moreover, treatment of primary myoblasts with the NF-
κB inhibitor curcumin stimulates myoblast fusion thereby
enhancing myogenesis and repair [125]. In line with these
in vitro ﬁndings, activation of the TNFα p a t h w a yb ym u s c l e
gene transfer inhibits regeneration in vivo, while muscle-
speciﬁc deletion of the heteromeric kinase complex IKK
was recently described to promote secondary myogenesis
in response to acute injury signals [126, 127]. Activation
of NF-κB downstream ROS formation is also capable of
stimulating the activity of inducible nitric oxide synthase
(iNOS),whoseroleinmyogenicprocessiscontroversial[24].
Some authors found that iNOS activity suppresses muscle
diﬀerentiation, whereas others reported that stimulation of
iNOS viaNF-κB represents a positive and necessary stimulus
for muscle diﬀerentiation, that iNOS activity paralleled
myogenesis from the early to later stages in H9C cells and
that ROS formed by NOX 2 were the basic trigger leading
to iNOS stimulation via NF-κB recruitment [24, 135, 136].
Blockage of this pathway, or inhibition of iNOS with speciﬁc
inhibitors,ledtodiﬀerentiativearrest.Also,arecentarticleby
Lee et al. [137] indicates that complex-I-derived superoxide
anions, produced through reverse electron transport, were
dismutated into H2O2 by MnSOD induced via NF-κB
activation and that H2O2 stimulated muscle diﬀerentiation
as a signaling messenger. Thus the scenario arising from
these results would indicate that ROS negatively or positively
regulate muscle diﬀerentiation via the signaling pathways
involving NF-κB activation.
Anotherevidencewhichlendssupporttothedetrimental
r o l eo fR O Si nm u s c l ed i ﬀerentiation comes from the studies
on the role of p66Shc in skeletal muscle ischemic injury.
p66Shc, along with its isoforms p46 and p52, constitutes the
mammalian Shc adaptor protein group. The three isoforms
share a common structure, but p66ShcA has the unique
feature of an additional domain at the N terminus which
contains a serine residue at position 36 (Ser-36) that is
phosphorylated in response to several stimuli, including
H2O2. Due to this feature p66 isoform regulates ROS
metabolism and apoptosis [138, 139]; indeed, a fraction of
p66ShcA is localized in the mitochondria where, as discussed
above,itproducesmitochondrialROSassignalingmolecules
for apoptosis [110, 111]. Interestingly, both p66ShcA KO
cells and mice display lower levels of intracellular ROS [139–
141] and are less prone to apoptosis induced by an array
of diﬀerent stimuli. Also, p66Shc KO mice are resistant
to ischemia-induced apoptosis and show decreased muscle
damage in response to hind limb ischemia [142]. More
recently, Zaccagnini et al. [143] unravelled the role of p66Shc
and ROS in muscular damage and regeneration following
acute hind limb ischemia in both WT and p66Shc KO
mice. WT mice showed detectable levels of oxidative stress
markers during the postischemic and regenerative stages;
on the contrary, the same markers were undetectable in
KO mice. More interestingly, although the initial ischemic
damage was identical and no advantage in terms of muscle
vascularizationandperfusionwasobservedinKOmice,their
regenerative capacity was signiﬁcantly higher as compared to
WT. Satellite cell populations were similar in both groups,
but those from KO mice showed a higher proliferation rate
at ﬁrst and spontaneous diﬀerentiation when cultured under
prodiﬀerentiative conditions. Finally, p66Shc KO satellite
cells were resistant to the myogenic inhibition induced by
H2O2 acute challenge or hypoxia. The authors proposed
diﬀerent and possible explanations for the above eﬀects.
The ﬁrst one involves the diﬀerent availability of NO—
whose promyogenic role has been discussed above—in
KO mice: since active p66Shc generates superoxide anions,
which consume available NO forming the toxic species
peroxynitrite, p66Shc KO mice would beneﬁt of higher NO
availability and would not suﬀer of peroxynitrite toxicity,
two eﬀects favouring myogenesis and muscle regeneration.
AnotherplausiblemechanisminvolvestheNAD+-dependent
histone deacetylase Sir2. Sir2 deacetylase activity is depen-
dent on the ﬂuctuation of cytosolic NAD+/NADH ratio,
that is, the cellular redox state [144]. Under conditions of
high ROS concentrations, NAD levels increase and promote
Sir2 activation, which in turn inhibits MyoD-dependent
transcription. p66Shc KO mice are characterized by lower
levels of ROS and, as a result, decreased Sir2 activity, that is a
condition which aﬀects MyoD functions to a lesser extent.
Finally, since oxidative DNA damage may trigger a diﬀer-
entiation checkpoint and cause a reversible inhibition of
myogenic diﬀerentiation targeting MyoD phosphorylation,Journal of Signal Transduction 9
such a checkpoint activation may be attenuated by p66ShcA
deletion, which results in decreased intracellular ROS levels.
With regard to prodiﬀerentiative eﬀects induced by ROS
in this context, in addition to the already cited report by
Lee et al. [137], it has been recently demonstrated that in
a non skeletal-muscle cell, that is, vascular smooth mus-
cle cells (VSMC), ROS increase their diﬀerentiation rate
after quiescence through a p38 MAPK-dependent pathway
[145]. Similarly, other studies focusing on ROS and muscle
metabolism, diﬀerentiation, and growth unravelled some
positive interactions with IGF-1 signaling (see below).
Again, the most likely explanation for these opposite
eﬀects is that cell fate may depend on the intracellular ROS
type (i.e., which is the prevailing reactive species) and level.
In fact, it is well known that ROS elicit a wide spectrum
of cellular responses, depending on their intracellular level
[146]. A low dose of ROS controls normal cellular signaling
pathways while an intermediate dose results in either tem-
p o r a r yo rp e r m a n e n tg r o w t ha r r e s t[ 147] .O b v i o u s l y ,ah i g h
dose of ROS causes cell death viaeither apoptotic or necrotic
mechanisms [142].
7.ROS andIGF-1Signaling
Growing evidence suggests that oxidative stress is responsi-
ble, as a causal or a concausal factor, for the pathogenesis
of many muscle diseases and muscle wasting [148, 149].
In muscle cells, IGF-1 is known to promote muscle welfare
inducing muscle hypertrophy and stimulate muscle-cell pro-
liferation, diﬀerentiation, and survival [123]. IGF-1 has also
been found to contribute to oxidative balance and to mediate
protective responses against iron-induced-lipid oxidative
stress in vivo [150]. Accordingly, Yang and colleagues [151]
demonstrated that IGF-1 displayed protective eﬀects on
muscle cells after oxidative stress: indeed, pretreatment with
IGF-1 protected muscle cells from H2O2-induced cell death
and enhanced their survival through promotion of the
antiapoptotic protein Bcl2. The same authors showed that
protection was via an IGF-1 subpathway: PI3K/Akt and
ERK1/2 MAPK pathways [151].
IGF-1 is a peptide hormone with a complex post-tra-
scriptional regulation, generating distinct isoforms, namely,
IGF-1Ea, IGF-1Eb, and IGF-1Ec (this latter also known
as mechano growth factor, MGF) [152]. Mouse models
have provided insights into the tissue-speciﬁc functions and
responses to ROS of the diﬀerent IGF-1 isoforms [152–155].
For example, in murine models, the local muscle isoform of
IGF-1 (mIGF-1, the orthologue of human MGF) has been
shown not only to activate proliferation of myoblasts [156],
but also to protect cardiomyocytes from oxidative stress via
the Sirtuin 1 deacetylase activity [157].
As to physical activity, although its role in regulating
the expression of speciﬁc IGF-1 isoforms has been widely
studied, data in the literature regarding humans are often
contradictory and are aﬀe c t e db ym a n yu n c o n t r o l l e dv a r i -
ables such as the lack of dietary control, heterogeneity
of subjects, their physical ﬁtness, diﬀerences in proposed
physical exercise, and time course of sampling [158–160].
Similarly to other pathways, ROS may regulate either
positively or negatively IGF-1 signaling [161]. Low levels
of endogenous ROS—due to their reversible oxidative inhi-
bition of protein tyrosine phosphatases (see also “ROS as
multipurpose local regulators of muscle cell functions”)—
induce the phosphorylation on speciﬁc tyrosine residues of
insulin receptor (IR) and IR substrates (IRS) protein(s),
thus facilitating the IGF-1 signaling. Indeed, the IRβ chain
contains multiple sites for the phosphorylation of tyrosine
that are sensitive targets of ROS such as H2O2 [162]. By
contrast, higher ROS levels inhibit IGF-1 signaling cascades
and recent evidence implicates ROS as downregulators of
IGF-1 signaling and inducers of insulin resistance and its
pathological sequelae [162].
However, ROS may be also involved in the activation
of “insulin-like” metabolic eﬀects by activating other non-
insulin-initiated signaling pathways: one of the most impor-
tant examples is the stimulation of glucose transport in
skeletal muscle during exercise [163, 164]. Skeletal muscle
contraction stimulates, as well as insulin, glucose transport
by up to 50-fold during maximal exercise in humans [165].
Adding exogenous ROS to skeletal muscle in vitro stimulates
glucose transport [166] whereas NAC, a potent antioxidant,
reduces contraction-mediated glucose uptake by about 50%
[167]. This eﬀect of NAC was associated with a similar
degree of inhibition of contraction-induced activation of
AMPK. This kinase is a fundamental signaling kinase
which, besides being involved in mitochondrial biogenesis
(see “ROS signaling and myogenic diﬀerentiation”), is also
known to upregulate the glucose uptake in muscle under
conditions of high AMP/ATP ratio, like hypoxia and muscle
contraction, forming a non-insulin-dependent pathway to
increase muscle glucose utilization [158, 168–172]. Thus the
proposedroleofROSinmediatingthestimulationofglucose
transport is related to skeletal muscle contraction, that
increases superoxide anion production via mitochondrial
respiration. Superoxide anion is rapidly converted to H2O2
by SOD, resulting in direct activation of AMPK, Glucose
transporter4(Glut4)translocationtotheplasmamembrane,
and an increase in glucose transport [173]. Moreover, in
muscle cells, NAC antagonized ROS-mediated increase in
g l u c o s eu p t a k ei nr e s p o n s et oc o n t r a c t i o n ,b u tn o tt o
insulin. Activation of AMPK in aerobic-exercise-induced
glucose uptake is paradigmatic of ROS participation in
physiologically-oriented signaling pathways relevant to the
homeostasis of the entire organism.
It has also been demonstrated that ROS regulate IGF-
1-induced myotube hypertrophy in vitro.I ti sw e l lk n o w n
that exercise-induced muscle hypertrophy mostly depends
on the increased local production of IGF-1 via activation of
the PI3K/Akt pathway [174, 175]; interestingly ROS, which
are being overproduced during exercise, contribute in a
feedforward manner to stimulate IGF1 net accumulation.
Previousreportsshowthattherearepositiveandnegative
interactions between ROS and IGF-1 synthesis in both
skeletal and VSMCs [176–178]. Treating VSMCs with H2O2
or XO augments both IGF-1 mRNA and IGF-1 protein
secreted into the cultured medium, indicating that ROS
enhance the IGF-1 autocrine system in VSMCs [176]. By10 Journal of Signal Transduction
contrast, we and others [5, 178] found that toxicologically
relevant concentrations of H2O2 negatively regulate the
IGF-1 mRNA levels in diﬀerentiating C2C12 myoblasts. In
our experience, oxidative insult signiﬁcantly decreased IGF-
1 mRNA expression levels [5] .C r ,n o t a b l y ,p r e v e n t e di t s
inhibition: moreover Cr is known to induce hypertrophy of
diﬀerentiating myoblasts via IGF-1 pathway [123].
Taken collectively, these results suggest that—although
ROS enhance IGF-1 signaling—there is a negative feedback
regulation of IGF-1 mRNA levels occurring with mildly toxic
ROS levels in C2C12 cells. Thus, ROS regulate IGF-1 action
via a variety of mechanisms, and the eﬀects are likely, again,
to be cell type and dose dependent.
Thus, ROS play a crucial role in the IGF-1 signaling
regulation and its biological action in muscle cells. However,
additional studies are necessary to better explain the phys-
iological signiﬁcance of these interactions in humans, with
particular regard to the identiﬁcation of the distinct actions
on the IGF-1 propeptide isoforms.
8.ROS as MultipurposeLocalRegulators of
Muscle Cell Functions
Similarly to other noninﬂammatory cells, skeletal muscle
cells produce transient ﬂuxes of ROS in response to an
array of diverse stimuli, such as intense contractile activity
[179, 180], heat stress [181], short-term disuse atrophy
[182], acute hypoxia [143, 183], acute osmotic stress [184],
and stretch [185]. Furthermore, locally produced waves of
ROS are also released by skeletal muscle in response to cell
surface receptor activation via cytokines, hormones, growth
factors [186–188], or nuclear receptor activation [189, 190].
Considering the large variety of diﬀerent stimuli converging
to ROS production along with their lack of chemical
speciﬁcity, it is hard to formulate a unitary explanation
of the physiological signiﬁcance of ROS in the responses
triggered by such divergent signals [188]. At this regard,
data published by Wright et al. [191] prompted these
authors to draw an attractive hypothesis which involves the
regulation of the protein phosphatases (PPases) “tone” in
muscle cells and tissue. PPases belong to two broad families,
the protein tyrosine PPases (about 112 human proteins)
and the serine/threonine PPases (about 31 proteins). These
two families are divided into further subclasses according
to their speciﬁcity (only tyrosine targets or tyrosine plus
serine/threoninetargets)or,withregardtothesecondfamily,
the subclasses characterized by a Zn2+/Fe2+ complex at the
catalytic site or by the Mn2+/Mg2+ dependence [191].
The redox sensitivity of the protein tyrosine PPases and
its potential biological importance is well documented in
vitro and in cell culture systems since the early 1990s [192,
193]. As to Ser/Thr PPases, their sensitivity to oxidants is
more controversial: calcineurin is the ﬁrst whose sensitivity
to oxidants has been clearly identiﬁed [194–196].
Interestingly, Wright et al. [191] found that not only
protein tyrosine PPases, but also Ser/Threo PPases are inhib-
ited by exposure to ROS or ROS generating agents (namely,
H2O2 and DMNQ, resp.). The relative sensitivity of diﬀerent
PPases to oxidation in the above scenario has not yet been
addressed. The mechanism by which PPases are oxidized is
likely to involve the vulnerability of their ubiquitous and
conservedcysteine-basedactivesite;moresurprisingandstill
unexplained is the observed inhibition of ser/threo PPases
which—with the exception of calcineurin—are best known
in literature as “relatively immune to oxidation”.
Indeed, the same study by Wright et al. [191] shows
that in muscle tissue even minimal, physiologically relevant
concentrations of oxidants, lead to an overall inhibition of
PPases’ activity. Notably, the concentrations used neither
aﬀected contractile function nor resulted in clear oxidative
stress.Consistently,thelevelofnetphosphorylationofawide
range of functionally diverging proteins was correspondingly
higher in treated muscle preparations. This latter data
suggests that oxidants are capable of aﬀecting a broad range
of PPases. Interestingly the majority of kinases are equally
sensitive to oxidants but, contrary to PPases, oxidants pro-
mote their activation. Since kinases operate sequentially as
ampliﬁcation chains, it is likely that the observed increase
in the net protein phosphorylation level under low-oxidative
stressing conditions is the result of a lower PPases activity
alongwithanincreasedkinasesactivity.Thesetwocombined
events promoted by ROS would obviously trigger and/or
aﬀect many diﬀerent signaling pathways, contributing to
orchestrate the ﬁnal cellular responses.
In summary, oxidants could function to regulate in vivo
global “phosphatase and kinase tone” and thus inﬂuence the
kinetics and ampliﬁcation of many kinase signaling path-
ways. With respect to skeletal muscle, such a scenario would
be of great biological and physiopathological relevance, since
muscle cells typically and continually produce ROS ﬂuxes
of diﬀerent duration, intensity, and localization, depending
on either intrinsic and extrinsic variables. Notably, such a
hypothesis ﬁts well with the hormetic nature of ROS.
9. Conclusion
The picture arising from this review indicates that ROS
activate and/or participate in many signaling pathways
promoting complex and diverging eﬀects in skeletal muscle
cells, ranging from positive to detrimental. As an example,
many studies have concluded that inactivity-induced ROS
production in skeletal muscle contributes to disuse muscle
atrophy [197, 198]. On the contrary, growing evidence also
suggests that intracellular ROS production is a required
signal for the normal remodelling that occurs in skeletal
muscle in response to repeated bouts of endurance exercise
[40, 199, 200]. How can the same trigger promote such
opposite eﬀects? Based upon current knowledge, it appears
that the mode and the situation characterizing skeletal
muscle cells exposure to ROS may account, at least in part,
for this apparent paradox. Transiently increased, moderate
levels of oxidative stress might represent a potentially health-
promoting process, whereas its uncontrolled persistence
and/or propagation might result in overwhelming cell dam-
age thus turning into a pathological event: for instance,
the role of ROS in inﬂammation ﬁts well with this model.
In addition, the complexity, the variety, the interplay, and
the functionally diverging roles of the signaling pathwaysJournal of Signal Transduction 11
a c t i v a t e do rm o d u l a t e db yR O Sc o n t r i b u t et of u r t h e rc o m -
plicate this scenario. Thus, a gradual and variable, rather
than a sharp, boundary is likely to characterize the transition
between the two types of ROS actions. Such a variable
“greyscaling” of ROS eﬀects may depend on extrinsic and
intrinsic situations such as, at least, (i) the concentration
of ROS, (ii) the type of reactive species involved, (iii) the
persistence of ROS activity, (iv) the localization of ROS
source, (v) the antioxidant capacity and the energy status
of muscle cells, (vi) their ability to adapt to oxidative stress
(which in vivo also depends on ageing and/or physical train-
ing), (vii) the diﬀerentiative status, for example, myoblasts
versus integrated myotubes, (viii) the absence/presence of
an inﬂammatory process, and (ix) the plasticity of the
signaling pathways triggered/aﬀected by ROS. The balance
between these factors will ultimately determine which type
of signal(s) and eﬀect(s) will prevail within the cell. Again,
the hormetic nature of ROS emerges as the key feature
of these species in many tissues, including skeletal muscle.
Careful titration of ROS levels within skeletal muscle cell
may therefore lie at the cross between the initiation and
progression of disease and cell death, the induction of
mitochondrial biogenesis, repair, and more generally cellular
metabolic health. Supplementation with exogenous antioxi-
dantsis being widelystudiedtoattainandmaintain an“ideal
titration” of ROS within skeletal muscle: unfortunately, at
the present, no clear indication of the beneﬁts arising from
supplemental antioxidant intake emerges from literature.
This reﬂects the need for further studies aimed at clarifying
how to regulate ROS levels to exploit their physiological
eﬀects and avoid their damages.
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